½ÃÀ庸°í¼­
»óǰÄÚµå
1511780

¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : µµ³Ê À¯Çüº°, ¼­ºñ½ºº°, ¼öÁ¤ ±â¼úº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

U.S. Sperm Bank Market Size, Share & Trends Analysis Report By Donor Type, By Service, By Fertilization Technique, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 80 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå ±Ô¸ð´Â 2024-2030³â CAGR 3.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 22¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

³Ãµ¿ º¸Á¸ ±â¼úÀÇ Çõ½Å, ºÒÀÓ Ä¡·á °ü±¤ÀÇ ÃâÇö, ºÒÀÓ Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼º Áõ°¡, À¯»ê À§Çè Áõ°¡°¡ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

March of Dimes¿¡ µû¸£¸é ÀӽŠ100°Ç Áß ¾à 20°ÇÀÌ À¯»êÀ¸·Î ³¡³ª¸ç, 3ȸ ¿¬¼Ó À¯»êÇÒ °æ¿ì ´Ù½Ã À¯»êÇÒ È®·üÀº ¾à 43%±îÁö Áõ°¡ÇÕ´Ï´Ù. ¶ÇÇÑ ³²¼º ºÒÀÓ Áõ°¡, Á¤ÀÚ·® ºÎÁ·, »çÁ¤ ¹®Á¦·Î ÀÎÇØ Á¤ÀÚÀºÇà ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹ °¢ ÁÖÀÇ ÀçÁ¤ Áö¿ø°ú Á¤ºÎ Áö¿øÃ¥ Áõ°¡´Â ºÒÀÓ Ä¡·áÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí Á¤ÀÚÀºÇà ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹¿¡¼­´Â ÀÇ·áºñ ºÎ´ã ÀûÁ¤È­¹ý(ACA), ÀÇ·áÀÚ¿ø¼­ºñ½º±¹(HRSA), ¹Ì±¹ º¸°Çº¹ÁöºÎÀÇ ¿©¼º°Ç°­±¹(OWH) µî Á¤ºÎ ±â°ü°ú ±¸»óÀÌ À¯»ê ¹®Á¦¸¦ Æ÷ÇÔÇÑ ¸ð¼º °Ç°­À» À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ Á¤ÀÚÀºÇà ½ÃÀå º¸°í¼­ÀÇ ÁÖ¿ä ³»¿ë :

  • ±âÁõÀÚ À¯Çüº°·Î´Â ¾Ë·ÁÁø ±âÁõÀÚ ºÎ¹®ÀÌ 55% ÀÌ»óÀÇ Á¡À¯À²·Î ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖÀ¸¸ç, 2023³â CAGRÀÌ 3.8%·Î °¡Àå ºü¸¥ ¼ºÀå¼¼¸¦ º¸¿´½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â Ä£±¸, °¡Á·, ÁöÀÎ µî °¡±î¿î ģôÀ¸·ÎºÎÅÍÀÇ ±âÁõÀÚ ¼±ÅÃÀÌ ²ÅÈü´Ï´Ù.
  • ¼öÁ¤ ±â¼úº°·Î´Â ±âÁõÀÚ ¼öÁ¤ÀÌ ±× ÀåÁ¡°ú ¿ëÀ̼ºÀ¸·Î ÀÎÇØ 2023³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¼­ºñ½ºº°·Î´Â Á¤¾× ºÐ¼® ºÎ¹®ÀÌ 2023³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº Á¤¾× ºÐ¼® ±â¼úÀÇ ¹ßÀü, º¸Á¶ »ý½Ä ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ºÒÀÓ·ü Áõ°¡ µîÀÔ´Ï´Ù.
  • 2024³â 1¿ù, ÀÚÀÌÅØ½º´Â FAMLINK BETA¸¦ ¹ßÇ¥ÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ÀÌ ÃÊ´ë Àü¿ë ÇÁ·Î±×·¥Àº ÀÚÀÌÅØ½ºÀÇ ±âÁõÀÚ¸¦ ÅëÇØ Àڳฦ Ãâ»êÇÑ ÀÚÀÌÅØ½ºÀÇ ¼ÒÁßÇÑ °í°´µéÀ» À§ÇØ °í¾ÈµÇ¾ú½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ¸ð½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ »ê¾÷ ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå : µµ³Ê À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • µµ³Ê À¯Çüº° ½ÃÀå Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â

Á¦5Àå ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå : ¼­ºñ½º ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼­ºñ½ºº° ½ÃÀå Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â

Á¦6Àå ¹Ì±¹ÀÇ Á¤ÀÚÀºÇà ½ÃÀå : ¼öÁ¤ ±â¼ú ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ÃÀå Á¡À¯À², 2023³â°ú 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¼öÁ¤ ±â¼úº° ½ÃÀå Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷º° ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀïÀÇ ºÐ·ù
  • º¥´õ ±¸µµ
  • ±â¾÷ °³¿ä
    • California Cryobank
    • Fairfax Cryobank
    • The Sperm Bank of California
    • Xytex Cryobank
    • Seattle Sperm Bank
    • International Sperm Bank
    • Reproductive Biology Institute
    • Midwest Sperm Bank
    • Cryo-Cell International
KSA 24.07.16

U.S. Sperm Bank Market Growth & Trends:

The U.S. sperm bank market size is anticipated to reach USD 2.25 billion by 2030, growing at a CAGR of 3.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Innovations in cryopreservation techniques, the emergence of fertility tourism, increasing access to infertility treatment and increase in the risk of miscarriages are the key factors driving the growth.

According to March of Dimes, approximately 20 in 100 pregnancies end in miscarriage, and following three consecutive miscarriages, the likelihood of experiencing another miscarriage increases to approximately 43%. In addition, the demand for sperm bank services is projected to grow due to increased levels of male infertility, insufficient sperm volume, and problems with ejaculation.

A rise in funding and supportive government initiatives across various states in U.S. is anticipated to boost the adoption of fertility treatments, thereby driving the demand for sperm banks. The U.S. government bodies and initiatives including the Affordable Care Act (ACA), Health Resources and Services Administration (HRSA), and Office on Women's Health (OWH), a part of the U.S. Department of Health and Human Services are making efforts for maternal and child health including issues with miscarriage.

U.S. Sperm Bank Market Report Highlights:

  • In terms of donor type, the known donor segment dominated the market with a share of more than 55% and the fastest CAGR of 3.8% CAGR in 2023. Key factors driving this segment growth include selecting a donor of choice specifically of a close relative including a friend, family member, or even an acquaintance.
  • Based on fertilization technique, the donor insemination segment held the largest revenue share in 2023 owing to the benefits and ease of the technique.
  • Based on service, the semen analysis segment dominated the market in 2023. Key factors driving this segment's growth include advancements in semen analysis techniques, growing demand for assisted reproductive technologies, and increasing infertility rates.
  • In January 2024, Xytex, plans to debut FAMLINK BETA. This exclusive, by-invitation-only program is designed to cater to Xytex's valued clients who have successfully welcomed a child using a Xytex donor.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Donor type
    • 1.2.2. Service
    • 1.2.3. Fertilization techniques
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Donor Type Outlook
    • 2.2.2. Service Outlook
    • 2.2.3. Fertilization Techniques
  • 2.3. Competitive Insights

Chapter 3. U.S. Sperm Bank Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Innovations in cryopreservation techniques
      • 3.2.1.2. Rising emergence of fertility tourism
      • 3.2.1.3. Increasing access to infertility treatment
      • 3.2.1.4. Increase in the risk of miscarriage
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stigma and social norms
  • 3.3. U.S. Sperm Bank Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Sperm Bank Market: Donor Type Estimates & Trend Analysis

  • 4.1. Donor Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Sperm Bank Market by Donor Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Known Donor
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Anonymous Donor
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Sperm Bank Market: Service Estimates & Trend Analysis

  • 5.1. Service Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Sperm Bank Market by Service Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Sperm storage
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.2. Semen analysis
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.4.3. Genetic consultation
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Sperm Bank Market: Fertilization Techniques Estimates & Trend Analysis

  • 6.1. Fertilization Techniques Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Sperm Bank Market by Fertilization Techniques Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Donor insemination
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 6.4.2. In vitro fertilization
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
  • 7.4. Company Profiles
    • 7.4.1. California Cryobank
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Fairfax Cryobank
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. The Sperm Bank of California
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Xytex Cryobank
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Seattle Sperm Bank
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. International Sperm Bank
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Reproductive Biology Institute
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Midwest Sperm Bank
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Cryo-Cell International
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦